RL
Rallybio Corporation
RLYB · NASDAQ
$16.92 +0.42% (+$0.07)
1M +0.71%
Market Cap $89.8M
P/E Ratio 1.97x
Div. Yield -
ROE 68.56%
Bulios Fair Price
$15.88
6.1% downside
Trenutna cena
$16.92
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RLYB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
85 /100
Cheap P/S 139.00x
P/B 0.95x
P/FCF 3.41x
Growth
0 /100
Declining Book val. growth 30.05%
Rev. growth N/A
FCF growth N/A
Profitability
50 /100
Moderate Net margin 7,051.24%
Op. margin 3,672.29%
FCF margin 4,077.40%
Quality
45 /100
Average ROE 68.56%
ROA 46.45%
Asset turnover 0.01x
Debt
100 /100
Low Current ratio 27.26x
Net debt/EBITDA -3.44x
Debt/Equity 0.00x
Stability
42 /100
Moderate EPS volatility 38.47%
Profitable years 0
Beta -0.85x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RLYB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Uden
Employees
7
Headquarters
New Haven
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report